RVL Pharmaceuticals PLC RVLP

Market cap
$14.1M
P/E
0.0×

A Cash Flow Statement is a financial report that details the cash inflows and outflows of a company over a specific period. It is divided into three sections: operating activities, investing activities, and financing activities. This statement helps assess the company’s liquidity, solvency, and overall financial health. By tracking cash movements, it provides insights into the company's ability to generate cash to fund operations, pay debts, and invest in growth. Businesses and investors use it to evaluate the sustainability of a company's cash flow and its financial stability.

Dec '16 Dec '17 Dec '18 Dec '19 Dec '20 Dec '21 Dec '22
Net Income
(41.82) (41.14) (109.68) (270.90) (79.59) (64.92) (51.69)
Depreciation & Amortization
45.06 119.44 185.79 340.76 94.48 17.66 16.75
Non Cash Items (Other)
(1.70) (29.94) (12.70) (20.52) 4.56 (0.01) (7.25)
Accounts Receivable Change
(12.53) 5.27 (17.04) 12.67 17.50 7.11 (0.90)
Change in inventories
12.56 2.89 (7.44) 3.08 3.37 2.60 0.05
Accounts Payable Change
(14.39) 0.59 (11.33) (16.37) (1.72) (0.13) (1.37)
Change in payables and accrued liability
(25.47) 13.79 5.40 (24.33) (17.79) (10.83) 2.32
Change in other assets and liabilities
(6.50) (13.06) 4.55 9.18 (3.21) (6.20) 4.28
Operating Cash Flow
(44.79) 57.84 37.56 33.57 17.59 (54.73) (37.81)
Capital expenditures
(13.93) (6.90) (4.13) (3.95) (3.13) (1.78) (0.75)
Change in intangibles (net)
(2.00) — — — — — —
Net Aquisitions
(437.53) (12.50) — (0.07) 0.05 0.09 0.88
Other investing activities
119.07 (8.38) — — (0.75) 118.15 (0.14)
Investing cash flow
(453.46) (19.40) (4.13) (4.02) (3.08) 116.45 0.13
Repayment/Issuance of Debt (Net)
338.24 (19.88) (54.48) (1.90) (50.13) (167.19) 18.10
Equity Repurchase (Common, Net)
— — 58.08 (2.79) 54.56 32.65 23.83
Other financial activities
82.28 (3.44) 0.00 290.03 (0.75) (0.78) (0.14)
Financing cash flow
420.52 (23.31) 3.60 (4.69) 3.68 (135.33) 41.78
Exchange Rate Adjustment
(0.32) 0.06 (0.94) 0.18 — — —
Change in Cash
(78.05) 15.18 36.09 25.03 18.19 (73.61) 4.10
Beginning Cash
97.61 19.56 34.74 70.83 95.87 114.05 40.44
Ending Cash
19.56 34.74 70.83 95.87 114.05 40.44 44.54
Stock Based Compensation
— — 1.97 4.93 4.93 7.59 4.07
Dividends Paid (Common)
0.00 0.00 0.00 0.00 0.00 0.00 0.00
Net Cash/Marketcap
0.00 0.00 0.00 0.00 0.00 0.00 0.00
Assets Liabilities Change (Total)
(46.33) 9.49 (25.86) (15.78) (1.86) (7.46) 4.39
Issuance/Purchase of Shares
— — 58.08 (2.79) 54.56 32.65 23.83
Other line items
Revenue per Employee
0.00 0.59 0.57 0.63 0.09 0.11 0.40

Fold the line items

In millions of $ except per-share values · columns are period end dates